SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-12-000156
Filing Date
2012-03-16
Accepted
2012-03-16 16:16:31
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE YEAR ENDED 12/31/2011 appy_10k-123111.htm 10-K 1301400
2 EXHIBIT 23 ex23.htm EX-23 3425
3 EXHIBIT 31.1 ex31x1.htm EX-31.1 17444
4 EXHIBIT 31.2 ex31x2.htm EX-31.2 17214
5 EXHIBIT 32 ex32.htm EX-32 11277
  Complete submission text file 0001079973-12-000156.txt   3767034

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT appy-20111231.xml EX-101.INS 520480
7 XBRL TAXONOMY EXTENSION SCHEMA appy-20111231.xsd EX-101.SCH 12294
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20111231_cal.xml EX-101.CAL 34266
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20111231_def.xml EX-101.DEF 13367
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20111231_lab.xml EX-101.LAB 155839
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20111231_pre.xml EX-101.PRE 88854
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 12697895
SIC: 2835 In Vitro & In Vivo Diagnostic Substances